Skip to content

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

DrugPatentWatch - Transform Data into Market Domination

Business Intelligence on Biologic and Small Molecule Drugs

Blog Home
DrugPatentWatch Home
Pricing
About
Contact

Drug Patent Expirations for the Week of February 1, 2026

By / February 2, 2026

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

VIZIMPRO (dacomitinib)

Pfizer Patent: 10,603,314 Expiration: Feb 2, 2026

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at

Related Posts:

Secure the Future of Branded Generics
Profit From Weak Drug Patents: Identifying Weak…
Own the Market: How Brand Companies Strategically…
Sell More After Patents Die
Pfizer's Portfolio as a Model for Precision in…
How Pharmaceutical Packaging Companies can Win the…
Master the Patent Cliff for Better Pharmacy Margins
Maximizing GLP-1 Market Exclusivity: Leveraging…
The Industrialization of Telehealth: A Strategic…
Pharma Doesn’t Buy on Features. They Buy on Fear of…
How to Survive the GLP-1 Patent War: A Strategic…
The Defensive Architecture of Biopharmaceutical…
Buy Low, Dispense High
Post-LOE? Win the War in the “Inactive” Ingredients:…
Own the Generic Entry Timeline: From Orange Book…
Cut Costs, Not Quality: How excipient vendors can…
Beat the Patent Thicket
How to keep your drug on the market for five extra years
Win the Patent Cliff: How the 12-Year Biologic…
Win the Patent Cliff: How to Track Patent Expiry and…
Using Drug Patents to Block Competitors: The Tactics…
Sell More Packaging Before Patents Die: Target drug…
The Data-Driven Guide to Winning the 2026 Patent Cliff
Profit from the Patent Gap

Winning the Exclusivity Game in Europe

The Cost of Combat: Deconstructing Drug Patent Litigation in the Pharmaceutical Age

Related Posts

Drug Patent Expirations for the Week of January 4, 2026

Patent Expiration / By

Drug Patent Expirations for the Week of January 18, 2026

Patent Expiration / By

Make Better Decisions

See Plans & Pricing

Recent Posts

The Patent Clock: How to Find Pharma’s Best Talent Before They Know They’re Looking
What Pharma Patent Litigation Actually Costs (It’s Not the Legal Bills)
Australia’s Drug Patent Clock: The Complete Guide to How Long Protection Actually Lasts
The Reformulation Playbook: How Pharma Uses 505(b)(2) to Lock In New Patents, Block Generics, and Reset Prices
The Drug Patent Cliff: A Procurement Manager’s Sourcing Playbook

Popular Posts

Russia Pharma Market Entry: IP Strategy, Patent Risks, and the Localization Playbook
China’s Irreplaceable Role in the Global Generic Drug API Supply Chain (2026 Report)
A Definitive Guide to Valuing Pharmaceutical and Biotech Companies
Analyzing the Chiral Switch: When Incremental Chemistry Becomes a Multi-Billion Dollar Patent Extension
The Patent Clock: How to Find Pharma’s Best Talent Before They Know They’re Looking
The Russian Pharmaceutical Industry: A Definitive Guide to Strategic Evolution, Geopolitical Realities, and Market Sovereignty
How to bypass the GLP-1 patent lock
The Small Molecule’s Resurgence: A Deep-Dive Strategic Analysis of FDA Approval Trends, IP Valuation, and Portfolio Economics for Pharma and Biotech Investors
Valuation of Pharmaceutical Companies: A Comprehensive Analysis of Key Considerations
CDMO Pricing: The Total Cost of Ownership Playbook for Pharma IP Teams and Portfolio Managers

Copyright © 2026 DrugPatentWatch - Transform Data into Market Domination

DrugPatentWatch - Transform Data into Market Domination

Subscribe to Free Updates

3,000+ other biopharma execs get our Drug Patent Expiration Alerts. You should too!

Get fresh news and insights, drug patent expirations & more…

EmailEnter your email address

Last Updated on February 2, 2026 by